Virgil® Investigative Study Platform

Virgil is WCG’s evidence-based solution that integrates clinical expertise and specialized technology in a targeted solution, reducing error rates for clinical endpoints by up to 85% through effective training and best practice implementation with eCOA.

Schedule Demo

Virgil provides digital clinical outcome assessments (eCOA) and data management for clinical trials.

From data entry to visit upload, Virgil fits seamlessly and easily into workflow at the study site while maximizing the potential of the data while minimizing the possibility of error. Virgil is built to ensure trial data is secure, accurate and complete.

From our 25 years of clinical experience in more than 500 global studies, we know Sponsors are often concerned about eCOA and quality of their data. And, we understand the challenges for sites, and the concerns patients have with participating in studies. That’s why we’ve built Virgil with Clinicians, for Clinicians, and with patients, for patients.

See how Sponsors are reducing error rates for clinical endpoints by 65% with our integrated clinical expertise and technology: SCHEDULE A DEMO

65% reduction of error rates
25 years of combined CNS experience
4-6 weeks 4-6 week implementation, quicker than any other eCOA provider

Heighten Detection of Treatment Effect

Virgil enables the integrated delivery of WCG’s clinical services, and in combination, enhances signal detection for all types of studies.

Optimize Patient Experience

With Virgil, patients are engaged throughout the study through messaging, availability of additional training, notifications of study visits and study information as configured with the study team.

Increase Overall Data Quality

Virgil incorporates clinical guidance for each assessment scale to ensure results are standardized across raters. Because Virgil was designed by clinicians for clinicians, our platform puts our years of experience in capturing and managing study data for global trials into the hands of sites and sponsors.

Virgil overcomes the challenges Sponsors have with other eCOA solutions

Industry leading scientific measurement and data quality

Smart scientific design: Measurement science and eCOA expertise are applied to the design and configuration of your solution.

Overall improved data quality: Our unique Vforms technology incorporates edit checks and clinical guidance to ensure the data captured in the assessments is accurate. Virgil PRO, our remote data capture solution for patients and caregivers, ensures immediate item-by-item uploads to our database, minimizing risk of data loss.

A complete patient engagement solution: built with patients, for patients

Patient Adherence: We create study solutions with a deep understanding of measurement science and functional design to help ensure questionnaires are completed to minimize missing entries. Patients complete questionnaires as required through use of reminders and alerts, while date/time stamping documents protocol adherence.

Patient Engagement: Patients are engaged throughout the study through messaging, availability of additional training, and notifications of study visits and study information. Real-time monitoring of patients is enabled by sites through the Virgil portal to view compliance, messages from patients and patient status.

Rapid setup and easy deployment

Quick development times: We leverage our proprietary Vform builder technology to enable views of the system as early as the kick-off meetings with sponsors, and completion of the system in only 4-6 weeks—quicker than any other eCOA provider.

Ease of enrollment: Avoid problems associated with manual entry of study/patient numbers into devices, through use of QR code technology.


The Proven Benefits of WCG's eCOA Solution

Virgil has substantial benefits for sponsors and CROs, as it reduces administrative burden, mitigates cost, and speeds trials. Such a system shows strong results with fewer errors and discrepancies, improved data quality, clearer signals, and standardized, accurate studies.

The ultimate beneficiaries of clearer signals and reduced administrative burden are of course CNS patients and their families. Their quality of life depends on medical advances; advances that improvements in the clinical trial process have vast potential to accelerate.

CHART DATA SOURCE: Negash S, et al. Virgil investigative study platform minimizes scoring discrepancies to improve signal detection. Presented at AAIC 2016, Toronto, Canada. F(1,298) = 38.4 p<.0001

Schedule a demo of Virgil

See for yourself how easy to use the Virgil system is, with a demonstration of our tablet, Vform technology, and patient-facing solutions. You’ll hear from us within 24 hours after contacting us.